Company Information

  

Address: 5 SYLVAN WAY
SUITE 300 
City: PARSIPPANY 
State: NJ 
Zip Code: 07054 
Telephone: 973-254-3560 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Pacira Pharmaceuticals, Inc., a Delaware corporation, is the holding company for our California operating subsidiary of the same name, or Pacira California. In March 2007, we acquired Pacira California from SkyePharma Holdings, Inc., or Skyepharma (referred to in this Annual Report on Form 10-K as the "Acquisition"). Unless the context requires otherwise, references to "Pacira," "we," the "Company," "us" and "our" in this Annual Report on Form 10-K refers to Pacira Pharmaceuticals, Inc., a Delaware corporation, and its subsidiaries. Corporate Information We were incorporated in Delaware under the name Blue Acquisition Corp. in December 2006 and changed our name to Pacira, Inc. in June 2007. In October 2010, we changed our name to Pacira Pharmaceuticals, Inc. Our principal executive offices are in Parsippany, New Jersey. Pacira®, EXPAREL®, DepoFoam®, DepoCyt® (United States (U.S.) registration), DepoCyte® (European Union (E.U.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
03/2018-0.81NAN/E
12/2017-1.07NAN/E
09/2017-1.30NAN/E
06/2017-1.71NAN/E
03/2017-1.44NAN/E
12/2016-1.02NAN/E
09/2016-0.07NAN/E
06/20160.73NA46.21

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.06Total Liab/Total Assets0.56
Net Inc/Total Assets-0.07Total Liab/Inv Cap0.61
Net Inc/Inv Cap-0.07Total Liab/Comm Equity0.52
Pretax Inc/Net Sales-0.15Interest Coverage Ratio-1.35
Net Inc/Net Sales-0.15Curr Debt/Equity0.00
Cash Flow/Net Sales0.06LTD/Equity0.99
SG&A/NetSales0.58Total Debt/Equity0.99
Asset Utilization   Liquidity  
Net Receivables Turnover9.31Quick Ratio6.22
Inventory Turnover2.42Current Ratio6.96
Inventory Day Sales0.01Net Rec/Curr Assets0.08
Net Sales/Work Cap0.86Inv/Curr Assets0.11
Net Sales/PP&E2.68  

Income Statement (Millions)

  3/31/2018 12/31/2017 9/30/2017 6/30/2017
Total Revenues(Net Sales) 74.61 79.08 67.34 70.93
Cost of Goods Sold 22.89 21.29 18.23 23.81
Selling & Admin Exps 44.28 39.29 40.90 44.05
Operating Income -6.94 8.46 -3.57 -15.78
Interest Exp 5.16 5.11 5.13 5.23
Pretax Income -10.65 4.63 -7.55 -19.71
Other Income 1.45 1.27 1.15 1.29
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -10.68 4.60 -7.60 -19.74

Balance Sheet (Millions)

Assets 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Cash & Short Term Investments 339.79 311.35 294.08 382.44
Receivables - Total 31.20 31.66 27.02 27.47
Inventories - Total 40.04 41.41 39.11 33.60
Total Current Assets 418.73 391.11 365.84 450.99
Net Property, Plant & Equipment 109.23 107.05 105.95 103.24
Total Assets 622.04 628.37 606.09 605.75
Liabilities        
Accounts Payable 48.04 55.79 52.02 57.19
Debt in Current Liabilities 0.33 0.32 0.32 0.32
Total Current Liabilities 48.37 56.22 52.34 57.51
Long-Term Debt 279.69 276.17 272.72 269.33
Total Liabilities 343.52 348.89 341.29 344.70
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.04 0.04 0.04 0.04
Retained Earnings -398.46 -389.14 -393.73 -386.13
Treasury Stock NA NA NA NA
Total Stockholders' Equity 278.52 279.48 264.80 261.05
Total Liabilities and Stockholders' Equity 622.04 628.37 606.09 605.75

Cash Flow Summary (Millions)

Categories 3/31/2018 12/31/2017 9/30/2017 6/30/2017
Net Cash Provided by Operating Activities -2.69 16.93 -2.81 3.66
Net Cash Provided by Investing Activities -10.29 8.70 -27.48 -61.15
Net Cash Provided by Financing Activities 0.42 2.28 2.69 2.34

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201385.55-63.91-1.93
12/2014197.67-13.72-0.39
12/2015249.001.860.95
12/2016276.37-37.95-1.02
12/2017286.63-42.61-1.07
Growth Rates35.29----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/1821243,471--




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.